Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emerging Biopharma
Research
Ventoux drug slows fibrosis in mouse model of hand condition
Industry veteran Kurt Harrington, who has Dupuytren's contracture, hopes his startup's drug will add an option for a condition with few treatments.
Helen Floersh
Mar 12, 2024 11:00am
VC closes $260M fund for early-stage biotechs
Feb 22, 2024 10:45am
2023 clinical trial launches drop 15% YOY
Feb 22, 2024 8:00am
Replicate's self-replicating RNA rabies vaccine clears phase 1
Feb 14, 2024 8:54am
Medicxi merges 6 dermatology biotechs into one, adds $100M
Feb 11, 2024 7:00pm
ReCode CEO Shehnaaz Suliman eyes second half IPO opportunity
Jan 17, 2024 10:31am
More News
CAR-T developer Kyverna is latest clue biotech IPOs are back
Jan 17, 2024 7:22am
For biotech dealmakers, it’s everything, everywhere all at once
Jan 17, 2024 7:00am
Disco gets down with €20M to find targets for cancer therapy
Jan 16, 2024 3:30am
Fierce Biotech M&A Tracker 2023: Karuna, Cerevel & more
Dec 22, 2023 10:24am
See more stories